| (USD) | Jun 2026 | Y/Y change |
|---|---|---|
| Revenue | 0.00 | — |
| Operating expense | — | — |
| Net income | -14.39M | — |
| Net profit margin | — | — |
| Earnings per share | — | — |
| EBITDA | — | — |
| Effective tax rate | — | — |
Over the past year, AARD returned -29.6% with dividends reinvested.
| Period | Total return |
|---|---|
| YTD | -47.6% |
| 1 year | -29.6% |
| All-time high | $13.52 (Jun 2025) |
Returns are total returns and include reinvested dividends. The all-time high is the highest monthly closing price on record.
See what $1,000 in AARD would be worth today ›No. Aardvark Therapeutics, Inc. has not paid a dividend in the past 12 months.
Aardvark Therapeutics, Inc. stock trades on NASDAQ under the ticker symbol AARD.
Aardvark Therapeutics, Inc. is part of the Healthcare sector.
Aardvark Therapeutics, Inc. has a market cap of 150.57M USD, based on the latest quote.
Aardvark Therapeutics, Inc. is expected to report earnings around Nov 12, 2026. That date is an estimate and has not been confirmed by the company.
